The Federal Circuit held today that non-disclosure by drug distribution giant McKesson of relevant information during prosecution of a patent rendered the patent unenforceable. The court therefore affirmed a judgment against McKesson after a four-day bench trial. McKesson Information Solutions, Inc. v. Bridge Medical, Inc. , No. 06-1517 (Fed. Cir. May 18, 2007).
The patent had something to do with an information system that aims to make absolutely sure that the right patient gets the right medicine. We think.